STRANDVEIEN 20 INVEST AS
Aksjeselskap (AS) · Lysaker, Norway · LEI 549300PB5EKEBVIEMV53
LEI active
Summary
STRANDVEIEN 20 INVEST AS is registered in Norway and entered in the “Register of Business Enterprises (Foretaksregisteret)” under number 912 433 315. Its legal form is Aksjeselskap (AS) – limited company (Norway). According to GLEIF, its ultimate parent is AS TAURUS (Norway), and its direct parent is SKIPS AS TUDOR (Norway). That group has 4 subsidiaries with LEIs in 1 country, 4 of them in Norway. The LEI was first issued on 22 Jun 2020 and the record was last updated on 28 Apr 2026; the next renewal is due by 25 Jun 2027.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | Aksjeselskap (AS) limited company (Norway) |
|---|---|
| Register | Register of Business Enterprises (Foretaksregisteret) · Register website |
| Registration number | 912 433 315 |
| Registration authority | The Brønnøysund Register Centre |
| Jurisdiction | Norway |
| Registered address | Strandveien 20, 1366 Lysaker, Norway |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 3 Sep 2013 |
| LEI | 549300PB5EKEBVIEMV53 |
| LEI status | active |
| LEI first issued | 22 Jun 2020 |
| LEI record last updated | 28 Apr 2026 |
| Next LEI renewal | 25 Jun 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
STRANDVEIEN 20 INVEST AS this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | SKIPS AS TUDOR | AS TAURUS |
| Accounting period | 31 Dec 2024 to 30 Dec 2025 | 31 Dec 2024 to 30 Dec 2025 |
| Evidence | supporting documents | supporting documents |
| Corroboration | fully corroborated | fully corroborated |
| Relationship start | 12 Jun 2022 | 12 Jun 2022 |
| Recorded at GLEIF since | 12 Jun 2022 | 12 Jun 2022 |
| Last updated | 28 Apr 2026 | 28 Apr 2026 |
| Record status | current | current |